![]() |
Novavax announced H1N1 VLP on April 14
The first death from swine flu occurred on April 13, when a diabetic woman from Oaxaca died from respiratory complications.
The following day, April 14, Novavax announced: Novavax, Inc. reported preclinical study results showing that an investigational H1N1 virus-like particle (VLP) vaccine based on the 1918 Spanish influenza strain protected against both the Spanish flu and a highly pathogenic H5N1 avian influenza strain. PDF format available at Novavax.com: http://www.novavax.com/download/rele...14_09%20FO.pdf -feeler |
All times are GMT. The time now is 09:08 PM. |
Powered by vBulletin® Version 3.8.4
Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
Project Avalon